Karianne Larsen

Karianne Larsen

Auto-generated profile, based on publicly available information

Karianne Larsen

Department of Research and Development, Norwegian Air Ambulance Foundation, Norway

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2021 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
KLKarianne Larsen
Karianne Larsen
HJHenriette S. Jæger
Henriette S. Jæger
LTLars H. Tveit
Lars H. Tveit
MHMaren R. Hov
Maren R. Hov
KTKjetil Thorsen
Kjetil Thorsen
KBKristi G. Bache
Kristi G. Bache
Background: Acute stroke treatment in mobile stroke units (MSU) is feasible and reduces time‐to‐treatment, but the optimal staffing model is unknown. We wanted to explore if integrating thrombolysis of acute ischemic stroke (AIS) in an anesthesiologist‐based emergency medical services (EMS) reduces time‐to‐treatment and is safe.Methods: A nonrandomized, prospective, controlled intervention study. Inclusion criteria: age ≥18 years, nonpregnant, stroke symptoms with onset ≤4 h. The MSU staffing is inspired by the Norwegian Helicopter Emergency Medical Services crew with an anesthesiologist, a paramedic‐nurse and a paramedic. Controls were included by conventional ambulances in the same catchment area. Primary outcome was onset‐to‐treatment time. Secondary outcomes were alarm‐to‐treatment time, thrombolytic rate and functional outcome. Safety outcomes were symptomatic intracranial hemorrhage and mortality.Results: We included 440 patients. MSU median (IQR) onset‐to‐treatment time was 101 (71–155) minutes versus 118 (90–176) minutes in controls, p = 0.007. MSU median (IQR) alarm‐to‐treatment time was 53 (44–65) minutes versus 74 (63–95) minutes in controls, p < 0.001. Golden hour treatment was achieved in 15.2% of the MSU patients versus 3.7% in the controls, p = 0.005. The thrombolytic rate was higher in the MSU (81% vs 59%, p = 0.001). MSU patients were more often discharged home (adjusted OR [95% CI]: 2.36 [1.11–5.03]). There were no other significant differences in outcomes.Conclusions: Integrating thrombolysis of AIS in the anesthesiologist‐based EMS reduces time‐to‐treatment without negatively affecting outcomes. An MSU based on the EMS enables prehospital assessment of acute stroke in addition to other medical and traumatic emergencies and may facilitate future implementation.

13 July 2022 in Stroke
Verified
Journal Article
Open access
PDF file
ULUlrikke Højslev Lund
Ulrikke Højslev Lund
ASAnna Stoinska-Schneider
Anna Stoinska-Schneider
KLKarianne Larsen
Karianne Larsen
KBKristi G. Bache
Kristi G. Bache
BRBjarne Robberstad
Bjarne Robberstad
Background: Acute ischemic stroke treatment in mobile stroke units (MSUs) reduces time-to-treatment and increases thrombolytic rates, but implementation requires substantial investments. We wanted to explore the cost-effectiveness of MSU care incorporating novel efficacy data from the Norwegian MSU study, Treat-NASPP (the Norwegian Acute Stroke Prehospital Project). Methods: We developed a Markov model linking improvements in time-to-treatment and thrombolytic rates delivered by treatment in an MSU to functional outcomes for the patients in a lifetime perspective. We estimated incremental costs, health benefits, and cost-effectiveness of MSU care as compared with conventional care. In addition, we estimated a minimal MSU utilization level for the intervention to be cost-effective in the publicly funded health care system in Norway. Results: MSU care was associated with an expected quality-adjusted life-year-gain of 0.065 per patient, compared with standard care. Our analysis suggests that about 260 patients with ischemic stroke need to be treated with MSU annually to result in an incremental cost-effectiveness ratio of about NOK385 000 (US$43 780) per quality-adjusted life-year for MSU compared with standard care. The incremental cost-effectiveness ratio varies between some NOK1 000 000 (US$113 700) per quality-adjusted life-year if an MSU treats 100 patients per year and to about NOK340 000 (US$38 660) per quality-adjusted life-year if 300 patients with acute ischemic stroke are treated. Conclusions: MSU care in Norwegian settings is potentially cost-effective compared with conventional care, but this depends on a relatively high annual number of treated patients with acute ischemic stroke per vehicle. These results provide important information for MSU implementation in government-funded health care systems.

1 June 2022 in Stroke
Verified
Journal Article
Open access
PDF file
KLKarianne Larsen
Karianne Larsen
HJHenriette S. Jæger
Henriette S. Jæger
MHMaren R. Hov
Maren R. Hov
KTKjetil Thorsen
Kjetil Thorsen
VSVolker Solyga
Volker Solyga
KBKristi G. Bache
Kristi G. Bache
Background: National Institutes of Health Stroke Scale (NIHSS) is the most validated clinical scale for stroke recognition, severity grading, and symptom monitoring in acute care and hospital settings. Numerous modified prehospital stroke scales exist, but these scales contain less clinical information and lack compatibility with in-hospital stroke scales. In this real-life study, we aimed to investigate if NIHSS conducted by paramedics in the field is a feasible and accurate prehospital diagnostic tool. Methods: This prospective cohort study is part of Treat-NASPP (Treat-Norwegian Acute Stroke Prehospital Project) conducted at a single medical center in Østfold, Norway. Sixty-three paramedics were trained and certified in NIHSS, and the prehospital NIHSS scores were compared with the scores obtained by in-hospital stroke physicians. Interrater agreement was assessed using a Bland-Altman plot with 95% limits of agreement. In secondary analysis, Cohen κ was used for the clinical categories NIHSS score of 0 to 5 and ≥6. As a safety measure, prehospital time was compared between paramedics conducting NIHSS and conventional paramedics. Results: We included 274 patients. The mean difference in NIHSS scores between the paramedics and the stroke physicians was 0.92 with limits of agreement from −5.74 to 7.59. Interrater agreement for the 2 clinical categories was moderate with a κ of 0.58. The prehospital NIHSS scoring was performed mean (SD) 42 (14) minutes earlier than the in-hospital scoring. Prehospital time was not significantly increased in the NIHSS-trained paramedic group compared with conventional paramedics (median [interquartile range] on-scene-time 18 [13–25] minutes versus 16 [11–23] minutes, P =0.064 and onset-to-hospital time 86 [65–128] minutes versus 84 [56–140] minutes, P =0.535). Conclusions: Paramedics can use NIHSS as an accurate and time efficient prehospital stroke severity quantification tool. Introducing NIHSS in the emergency medical services will enable prehospital evaluation of stroke progression and provide a common language for stroke assessment between paramedics and stroke physicians. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03158259.

5 January 2023 in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Verified
Journal Article
Open access
PDF file
HJHenriette S. Jæger
Henriette S. Jæger
DTDitte Tranberg
Ditte Tranberg
KLKarianne Larsen
Karianne Larsen
JVJan B. Valentin
Jan B. Valentin
RBRolf Blauenfeldt
Rolf Blauenfeldt
MGMartin F. Gude
Martin F. Gude
Introduction: Rapid identification and treatment of stroke is crucial for the outcome of the patient. We aimed to determine the performance of glial fibrillary acidic protein (GFAP) independently and in combination with the Prehospital Stroke Score (PreSS) for identification and differentiation of acute stroke within 4.5 h after symptom onset. Patients and methods: Clinical data and serum samples were collected from the Treat-Norwegian Acute Stroke Prehospital Project (Treat-NASPP). Patients with suspected stroke and symptoms lasting ≤ 4.5 h had blood samples collected and were evaluated with the National Institutes of Health Stroke Scale prospectively. In this sub study, NIHSS was retrospectively translated into PreSS and GFAP was measured using the sensitive single molecule array (SIMOA). Results: A total of 299 patients with suspected stroke were recruited from Treat-NASPP and included in this study (44% acute ischemic stroke (AIS), 10% intracranial hemorrhage (ICrH), 7% transient ischemic attack (TIA), and 38% stroke mimics). ICrH was identified with a cross-fold validated area under the receiver-operating characteristic curve (AUC) of 0.73 (95% CI 0.62–0.84). A decision tree with PreSS and GFAP combined, first identified patients with a low probability of stroke. Subsequently, GFAP detected patients with ICrH with a 25.0% sensitivity (95% CI 11.5–43.4) and 100.0% specificity (95% CI 98.6–100.0). Lastly, patients with large-vessel occlusion (LVO) were detected with a 55.6% sensitivity (95% CI 35.3–74.5) and 82.4% specificity (95% CI 77.3–86.7). Conclusion: In unselected patients with suspected stroke, GFAP alone identified ICrH. Combined in a decision tree, GFAP and PreSS identified subgroups with high proportions of stroke mimics, ICrH, LVO, and AIS (non-LVO strokes).

4 February 2022 in Trials
Verified
Journal Article
Open access
PDF file
HBHelge Fagerheim Bugge
Helge Fagerheim Bugge
MGMona Guterud
Mona Guterud
KBKristi C. G. Bache
Kristi C. G. Bache
ABAnne-Cathrine Braarud
Anne-Cathrine Braarud
EEErik Eriksen
Erik Eriksen
MHMaren Ranhoff Hov
Maren Ranhoff Hov
Background: Less than 50% of stroke patients in Norway reach hospital within 4 h of symptom onset. Early prehospital identification of stroke and triage to the right level of care may result in more patients receiving acute treatment. Quality of communication between paramedics and the stroke centre directly affects prehospital on-scene time, emphasising this as a key factor to reduce prehospital delay. Prehospital stroke scales are developed for quick and easy identification of stroke, but have poor sensitivity and specificity compared to an in-hospital assessment with the National Institutes of Health Stroke Scale (NIHSS). The aim of the Paramedic Norwegian Acute Stroke Prehospital Project (ParaNASPP) is to assess whether a structured learning program, prehospital NIHSS and a mobile application facilitating communication with the stroke physician may improve triage of acute stroke patients. Methods: A stepped wedge cluster randomised controlled intervention design will be used in this trial in Oslo, Norway. Paramedics at five ambulance stations will enrol adult patients with suspected stroke within 24 h of symptom onset. All paramedics will begin in a control phase with standard procedures. Through an e-learning program and practical training, a random and sequential switch to the intervention phase takes place. A mobile application for NIHSS scoring, including vital patient information for treatment decisions, transferring data from paramedics to the on-call stroke physician at the Stroke Unit at Oslo University Hospital, will be provided for the intervention. The primary outcome measure is positive predictive value (PPV) for prehospital identification of patients with acute stroke defined as the proportion of patients accepted for stroke evaluation and discharged with a final stroke diagnosis. One thousand three hundred patients provide a 50% surplus to the 808 patients needed for 80% power to detect a 10% increase in PPV. Discussion: Structured and digital communication using a common scale like NIHSS may result in increased probability for better identification of stroke patients and less stroke mimics delivered to a stroke team for acute diagnostics and treatment in our population. Trial registration: ClinicalTrials.gov NCT04137874. Registered on October 24, 2019.

1 December 2025 in European Stroke Journal
Verified
Journal Article
Closed access
BMBerend Markhorst
Berend Markhorst
CJCaroline Jagtenberg
Caroline Jagtenberg
MHMaren Ranhoff Hov
Maren Ranhoff Hov
RMRob van der Mei
Rob van der Mei
KLKarianne Larsen
Karianne Larsen
Introduction: A Mobile Stroke Unit (MSU) enables prehospital acute stroke assessment, which leads to increased treatment rates and improved patient outcomes. However, for optimal utilization of the specialized resource, identifying the proper location for the MSU is crucial. Motivated by this, our goal was to find the optimal placement of an MSU in the greater Oslo area using geospatial mapping, and to explore how the location may influence acute stroke treatment. Methods: Historical data on suspected and confirmed strokes with the respective geospatial data and calculated travel times were analyzed using a mathematical optimization model based on the Maximum Coverage Location Problem (MCLP) and solved with the Gurobi solver. The model is universal and may be adapted to other regions and countries. Results: The optimal base location for a single MSU in the greater Oslo area would increase the coverage of stroke patients by 24%. The rendez-vous approach yields a more than doubled coverage for confirmed stroke patients. In the optimal location, the MSU has the potential to reduce time to thrombolysis by 28 minutes (28%) and time to thrombectomy by around 35 minutes (20%). Conclusion: Strategic placement of an MSU in the greater Oslo area significantly increases patient coverage and may reduce treatment times in acute stroke. Geospatial analyses have the potential to aid decision making on MSU location, optimize prehospital acute stroke assessment and improve patient outcomes.